Genetic engineering and stem cell therapy for the treatment of heart failure

  • Authors

    • Silpa Rajan
    • Minu Lalitha Madhavu
    2018-06-08
    https://doi.org/10.14419/ijet.v7i2.33.15533
  • Arrhythmia, Embryonic Cardiac Stem Cells (ECSCSS), Heart Failure (HF), Myocardial Infarction (MI), Multipotent and Pluripotent Stem Cells.

  • Endogenous cardiac stem cells (eCSCSs) are defined as tissue specific progenitor cells concealed within human heart. Adult heart was thought primarily as a post mitotic organ devoid of any regenerative capacity. But eCSCSs proves the existence of immature cycling myo-cytes in adult myocardium which promotes regeneration after infarction. In addition to the restocking ofheart tissue, eCSCs put up in turn marks major and paramount role in growth and development of heart tissue.

    Myocardial infarction has become a major cause of death of a very large population per year and those who outlast live with heart stoppage. The permanent dropping of cardiomyocytes at the time of infarction makes a healthy body susceptible to irregular heartbeat called arrhythmia as electro-mechanically dysfunctional tissues are fabricated. Under this condition, heart becomes unable to pump sufficient amount of blood to the body including heart, lungs, brain leading to cardiovascular collapse. Brain and other organs can’t work properly and may shut down or will be damaged when heart doesn't pump blood productively.

     Due to arrhythmia, as heart doesn’t pump blood effectively to various vital organs of the body, they can't function properly and eventually wear off. To reinstate cardiac function in heart failure, potential therapeutic approaches via cell based therapies using multipotent (adult) and pluripotent (embryonic) stem cells are used.

     

     

     

  • References

    1. [1] Genetic engineering and stem cells :combinatorial approaches for cardiac cell therapy by Robert D.Kirkton and NenadBursac.

      [2] Cardiac regeneration by resident stem and progenitor cells in human heat by StigLyngbaek, Mikael Schneider, Jakob L. Hansen, Soren P. Sheikh.

      [3] Myoblast transplantation for heart failure by Menasche P, Hagege AA, Scorsin M, Puzet B, Desnos M, Duboc D, Schwartz K, vilquin JT, Marolleau JP.

      [4] Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure by KonradUrbanek, Daniele Torella , Farooq Sheikh, DariaNurzynska.

      [5] Multipotent and pluripotent stem celld for heart regeneration: wha are the pros and cons?bySong –Yan Liao and Hung- Fat Tse.

      [6] E.L.Olivares, et al, “Bone marrow stromal cels improve cardiac performance in healed infarcted rat hearts,†Am.J. Physical., vol. 287, pp.H464-H470, 2004.

      [7] L.C, Amado, et al., “Cardiac repair with intra-myocardial injection of allogeneic mesenchymal stem cells after myocardial infarction,†pp.11474-11479, 2005.

      [8] R.R. Smith, et al., “Regenerative potential of cardiosphere-derived cells expanded cells expanded from percuntaneousendomyocardialbiopsy secimens,†Circulation, vol.115, pp., 896-908, 2007.

      [9] AnversaP,Rota M, Urbanek k, Hosoda T, SonnenblickEH,Leri A, Kajstura J, Bolli R(2005) Myocardial aging- a stem cell problem, Basic Res Cardiol 100; 482-493

      [10] Caplan AI, Mesenchymal stem cells. J Orthop Res 9; 641-650, 1991.

      [11] Badroff C, BrandesRP,Popp R, Rupp S, Urbich C, Aicher A, Fleming I, Busse R, Zeiher AM ,Dimmeler S (2003) Trans- differentiation of Blood- derived Human Adult Endothelial Progenitor Cells Into Functionally Active cardiomyocytes , Circulation 107:1024-1032.

      [12] Davis ME,HseihPC,Grodzinsky AJ, Lee RT (2005) Custom design of the cardiac microenvironment with biomaterial, Cir Res 97; 8-15.

      [13] I.H.Park, et al.,†reprogramming of human somatic cells to pluripotency with defined factors,†Nature, vol 451, pp, 141-146, 2008.

  • Downloads

  • How to Cite

    Rajan, S., & Lalitha Madhavu, M. (2018). Genetic engineering and stem cell therapy for the treatment of heart failure. International Journal of Engineering & Technology, 7(2.33), 924-925. https://doi.org/10.14419/ijet.v7i2.33.15533